ClinicalTrials.Veeva

Menu

COach2Quit TRIAL: Assessing a Prototype Personal Carbon Monoxide Monitor for Smoking Cessation (C2Q)

Johns Hopkins University logo

Johns Hopkins University

Status

Completed

Conditions

Smoking
Smoking Cessation

Treatments

Device: Individualized carbon monoxide (iCO) monitor
Behavioral: Cessation counseling
Other: COach2Quit smartphone application

Study type

Interventional

Funder types

Other

Identifiers

NCT03142932
IRB00124820

Details and patient eligibility

About

The objective of this study is to conduct a randomized controlled trial to determine whether the use of the COach2Quit application (app) reduces smoking more than brief advice for smoking cessation. The investigators hypothesize that real time biomarker feedback and messaging support from the COach2Quit app will lead to greater smoking cessation rates than brief anti-smoking advice alone. If effective, the COach2Quit app could be an easily accessible and cost-effective tool to help smokers quit. The findings from this trial could have implications for the delivery of future outpatient smoking cessation programs.

Full description

The goal of this randomized controlled trial is to assess the efficacy of the novel COach2Quit smartphone application by determining whether the use of this app reduces smoking more than brief anti-smoking advice alone. This will be a two-arm individually randomized trial and participants who are currently smoking will be assigned 1:1 to either study arm. Smoking behavior will be measured through self-report at baseline, 2-week and 1-month follow up visits. Smoking behavior will also be verified by 2 biomarker measurements: carbon monoxide breath test and urine cotinine, collected at baseline, 2-week and 1-month follow-up visits. In addition, participants will receive weekly follow-up calls. The primary outcome will be smoking cessation at the 1-month follow-up visit.

Enrollment

102 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ≥18 years of age
  • current, daily smokers
  • agree to participate and anticipate to be living in Baltimore for at least 2 months
  • own a phone that is compatible with the app
  • be willing to set at baseline assessment a quit date within 2 weeks

Exclusion criteria

  • are suffering from any unstable medical condition precluding the use of the CO monitor (e.g. severe COPD)
  • are currently using smokeless tobacco including e-cigarettes
  • are currently using nicotine replacement therapy or other smoking cessation treatment
  • are pregnant, determined by participant self-report
  • have a negative baseline result on both urine cotinine AND CO monitor

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

102 participants in 2 patient groups

Control
Active Comparator group
Description:
A certified smoking cessation interventionist (SCI) will deliver standardized smoking cessation counseling using the National Cancer Institute (NCI) 5 A's model.
Treatment:
Behavioral: Cessation counseling
COach2Quit
Experimental group
Description:
A certified smoking cessation interventionist (SCI) will deliver standardized smoking cessation counseling using the National Cancer Institute's 5 A's model. Participants in the COach2Quit arm will be provided with an individualized carbon monoxide (iCO) monitor along with instructions on the use of the monitor and the COach2Quit application.
Treatment:
Behavioral: Cessation counseling
Other: COach2Quit smartphone application
Device: Individualized carbon monoxide (iCO) monitor

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems